According to projections from the World Health Organization, depression will be the second leading cause of disability in the developed world by 2020. Primary care clinicians (PCCs) care for approximately two thirds of depressed individuals. Rates of guideline concordant care for depression, however, are suboptimal and patient outcomes are often poor. A variety of strategies have been tested to improve patient outcomes including: physician educat...
De Evidence Synthesis for Determining the Responsiveness of Depression Questionnaires and Optimal Treatment Duration for Antidepressant Medications is een populaire optie voor Medisch onderzoek. Esy heeft 1 prijs gevonden, de goedkoopste keuze is volgens ons Bol, maar bekijk de andere aanbieders om het zeker te weten. Links openen in een nieuwe tabblad. Bekijk hier onder de product specificaties. Meer product informatie beschikbaar bij Bol.
Evidence Synthesis for Determining the Responsiveness of Depression Questionnaires and Optimal Treatment Duration for Antidepressant Medications is onder andere te koop bij: Bol. Esy raadt altijd aan om meerdere aanbieders te bekijken om geen last minute deals mis te lopen.
Modern analytical biotechnology is focused on the use of a set of enabling platform technologies that provide contemporary, state-of-the-art tools for genomics, proteomics, metabolomics, drug discover...